ISSN 0303-5212

Advertising Policy

Rawal Medical Journal

Advertising Policy

Editorial decision is not be influenced by advertising revenue or reprint potential. Editorial and advertising functions at the journal are independent. Advertisers and donors have no control over editorial material under any circumstances.

We require all advertisements to clearly identify the advertiser and the product or service being offered. In the case of drug advertisements, the full generic name of each active ingredient should appear. Commercial advertisements is be placed adjacent to any editorial matter that discusses the product being advertised, nor adjacent to any article reporting research on the advertised product, nor should they refer to an article in the same issue in which they appear. Ads have a different appearance from editorial material so there is no confusion between the two. Similar limitations (for the regular journal as well as supplements) may include placement of ads for related products on the front, rear, or inside cover pages of an issue that carries an editorial or original article on that topic.

Advertisements may not be deceptive or misleading. Exaggerated or extravagantly worded copy  are not be allowed. Advertisements are not be accepted if they appear to be indecent or offensive in either text or artwork, or contain negative content of a personal, racial, ethnic, sexual orientation, or religious character.

We have the right to refuse any advertisement for any reason. The decision as to acceptance (and any questions about eligibility raised by readers or others) is made in consultation with the journal's editorial content team and the editorial team is regularly informed about the evaluation of advertising, especially those that are refused due to non-compliance with the journal's guidelines.